Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorReid, Michelle D.
dc.contributor.authorBalci, Serdar
dc.contributor.authorOhike, Nobuyuki
dc.contributor.authorXue, Yue
dc.contributor.authorKim, Grace E.
dc.contributor.authorTajiri, Takuma
dc.contributor.authorAdsay, Volkan
dc.date.accessioned2019-08-13T12:10:23Z
dc.date.accessioned2019-08-13T15:56:51Z
dc.date.available2019-08-13T12:10:23Z
dc.date.available2019-08-13T15:56:51Z
dc.date.issued2016
dc.identifier.issn0893-3952
dc.identifier.issn1530-0285
dc.identifier.urihttps://dx.doi.org/10.1038/modpathol.2016.124
dc.identifier.urihttp://hdl.handle.net/11446/2399
dc.descriptionWOS: 000389391200013en_US
dc.descriptionPubMed ID: 27586202en_US
dc.description.abstractHistologic classification of ampullary carcinomas as intestinal versus pancreatobiliary is rapidly becoming a part of management algorithms, with immunohistochemical classification schemes also being devised using this classification scheme as their basis. However, data on the reproducibility and prognostic relevance of this classification system are limited. In this study, five observers independently evaluated 232 resected ampullary carcinomas with invasive component >3 mm. Overall interobserver agreement was 'fair' (kappa 0.39; P< 0.001) with complete agreement in 23%. Using agreement by 3/5 observers as 'consensus' 40% of cases were classified as 'mixed' pancreatobiliary and intestinal. When observers were asked to provide a final diagnosis based on the predominant pattern in cases initially classified as mixed, there was 'moderate' agreement (kappa 0.44; P< 0.0001) with 5/5 agreeing in 35%. Cases classified as pancreatobiliary by consensus (including those with pure-pancreatobiliary or mixed-predominantly pancreatobiliary features) had shorter overall (median 41 months) and 5-year survival (38%) than those classified as pure-intestinal/mixed-predominantly intestinal (80 months and 57%, respectively; P= 0.026); however, on multivariate analysis this was not independent of established prognostic parameters. Interestingly, when compared with 476 cases of pancreatic ductal adenocarcinornas, the pancreatobiliary-type ampullary carcinomas had better survival (16 versus 41 months, P< 0.001), even when matched by size and node status. In conclusion, presumably because of the various cell types comprising the region, ampullary carcinomas frequently show mixed phenotypes and intratumoral heterogeneity, which should be considered when devising management protocols. Caution is especially warranted when applying this histologic classification to biopsies and tissue microarrays. While ampullary carcinomas with more pancreatobiliary morphology have a worse prognosis than intestinal ones this does not appear to be an independent prognostic factor. However, pancreatobiliary-type ampullary carcinomas have a much better prognosis than their pancreatic counterparts.en_US
dc.language.isoengen_US
dc.publisherNATURE PUBLISHING GROUPen_US
dc.identifier.doi10.1038/modpathol.2016.124en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleAmpullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 casesen_US
dc.typearticleen_US
dc.relation.journalMODERN PATHOLOGYen_US
dc.departmentDBÜen_US
dc.identifier.issue12en_US
dc.identifier.volume29en_US
dc.identifier.startpage1575en_US
dc.identifier.endpage1585en_US
dc.contributor.authorID0000-0002-1308-3701en_US
dc.contributor.authorID0000-0003-2747-1366en_US
dc.contributor.authorID0000-0002-2693-0666en_US
dc.contributor.authorID0000-0002-7852-3851en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Reid, Michelle D. -- Balci, Serdar -- Xue, Yue -- Memis, Bahar -- Krasinskas, Alyssa M. -- Adsay, Volkan] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA -- [Ohike, Nobuyuki] Showa Univ, Fujigaoka Hosp, Dept Pathol, Yokohama, Kanagawa, Japan -- [Kim, Grace E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA -- [Tajiri, Takuma] Tokai Univ, Hachioji Hosp, Dept Pathol, Tokyo, Japan -- [Coban, Ipek] Istanbul Bilim Univ, Florence Nightingale Hosp, Dept Pathol, Istanbul, Turkey -- [Dolgun, Anil] Hacettepe Univ, Fac Med, Dept Biostat, Ankara, Turkey -- [Basturk, Olca] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA -- [Kooby, David A. -- Sarmiento, Juan M. -- Maithel, Shishir K.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA -- [El-Rayes, Bassel F.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA USA -- [Balci, Serdar] Yildirim Beyazit Univ, Dept Pathol, Ankara, Turkey -- [Basturk, Olca] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USAen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster